当前位置:首页 - 行情中心 - 正海生物(300653) - 财务分析

正海生物

(300653)

  

流通市值:37.31亿  总市值:37.31亿
流通股本:1.80亿   总股本:1.80亿

正海生物(300653)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2025年半年度实现净利润0.46亿元,每股收益0.26元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2025年半年度最新股东权益85355.55万元,未分配利润45485.53万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2025年半年度最新总资产94062.72万元,负债8707.17万元。

利润表
报告期2025-06-302025-03-312024-12-312024-09-30
营业总收入187,841,101.8897,415,845.21363,225,351.49291,348,252.99
营业总成本143,865,571.1669,470,342.54235,693,995.77167,592,844.19
其他经营收益
营业利润51,404,192.1731,214,045.93152,507,129.31143,286,089.85
利润总额51,413,172.2531,238,886.07152,377,776.26143,368,675.11
净利润46,485,732.6626,626,723.19134,639,109125,055,698.08
每股收益
其他综合收益----
综合收益总额46,485,732.6626,626,723.19134,639,109125,055,698.08
资产负债表
报告期2025-06-302025-03-312024-12-312024-09-30
流动资产:
流动资产合计683,629,211.4749,093,740.23712,700,493.26708,663,060.52
非流动资产:
非流动资产合计256,998,008.58262,607,080.24267,413,128.73268,738,008.23
资产总计940,627,219.981,011,700,820.47980,113,621.99977,401,068.75
流动负债:
流动负债合计76,631,857.1786,064,031.680,789,269.771,359,025.73
非流动负债:
非流动负债合计10,439,875.4110,225,933.9410,540,220.5511,191,600.82
负债合计87,071,732.5896,289,965.5491,329,490.2582,550,626.55
所有者权益(或股东权益):
归属于母公司股东权益合计853,555,487.4915,410,854.93888,784,131.74894,850,442.2
股东权益合计853,555,487.4915,410,854.93888,784,131.74894,850,442.2
负债和股东权益合计940,627,219.981,011,700,820.47980,113,621.99977,401,068.75
现金流量表
报告期2025-06-302025-03-312024-12-312024-09-30
经营活动产生的现金流量:
经营活动现金流入小计216,993,285.97113,607,783.91405,312,446.2306,772,298.59
经营活动现金流出小计169,320,341.7574,659,972.78253,928,490.48185,298,793.83
经营活动产生的现金流量净额47,672,944.2238,947,811.13151,383,955.72121,473,504.76
投资活动产生的现金流量:
投资活动现金流入小计485,580,551.71293,907,815.971,382,370,699.471,108,343,284.75
投资活动现金流出小计514,628,107.51382,133,869.211,286,708,179.42969,065,676.33
投资活动产生的现金流量净额-29,047,555.8-88,226,053.2495,662,520.05139,277,608.42
筹资活动产生的现金流量:
筹资活动现金流入小计----
筹资活动现金流出小计81,714,377-193,933,815.68178,280,236.25
筹资活动产生的现金流量净额-81,714,377--193,933,815.68-178,280,236.25
汇率变动对现金及现金等价物的影响----
现金及现金等价物净增加额-63,088,988.58-49,278,242.1153,112,660.0982,470,876.93
期末现金及现金等价物余额48,590,439.4162,401,185.88111,679,427.99141,037,644.83
补充资料:
现金及现金等价物的净增加额-63,088,988.58-53,112,660.09-
最新报告期:2025-08-04
研究机构分析师预测每股收益(元)更新日
2025年2026年2027年
华泰证券代雯,孔垂岩,王殷杰0.650.720.802025-08-04
TOP↑